Nexgel (NXGL) Income from Continuing Operations (2018 - 2025)
Nexgel (NXGL) reported Income from Continuing Operations of 928000.0 for Q4 2025, down 12.62% on a YoY basis from 1062044.44 in Q4 2024, and down 43.43% quarter-over-quarter from 647000.0 in Q3 2025.
Nexgel (NXGL) Income from Continuing Operations (2018 - 2025) Analysis & Trends
Nexgel has reported Income from Continuing Operations for 8 years, with the latest figure at 928000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations fell 12.62% year-over-year to 928000.0; the trailing twelve-month figure through Dec 2025 stood at 2893000.0 (up 16.44% YoY), and the FY2025 full-year result was 2789000.0, up 15.54% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 928000.0, down from 647000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 552000.0 in Q3 2023, with the low at 1836000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 936300.0 across 5 years, with a median of 825000.0 in 2021.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations tumbled 161.09% — and 2022, when it jumped 63.29%.
- Nexgel's Income from Continuing Operations stood at 1765000.0 in 2021, then jumped by 63.29% to 648000.0 in 2022, then slumped by 83.18% to 1187000.0 in 2023, then surged by 30.58% to 824000.0 in 2024, then fell by 12.62% to 928000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 928000.0 (Q4 2025), 647000.0 (Q3 2025), and 640000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | -928,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -928,000.00 |
| Sep 30, 2025 | -647,000.00 |
| Jun 30, 2025 | -640,000.00 |
| Mar 31, 2025 | -678,000.00 |
| Dec 31, 2024 | -824,000.00 |
| Sep 30, 2024 | -754,000.00 |
| Jun 30, 2024 | -979,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Dec 31, 2023 | -1.19 Mn |
| Sep 30, 2023 | -552,000.00 |
| Jun 30, 2023 | -642,000.00 |
| Mar 31, 2023 | -807,000.00 |
| Dec 31, 2022 | -648,000.00 |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -1.04 Mn |
| Mar 31, 2022 | -1.84 Mn |
| Dec 31, 2021 | -1.77 Mn |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -826,000.00 |
| Mar 31, 2021 | -704,000.00 |